OKOLICSANYI, STEFANO
 Distribuzione geografica
Continente #
NA - Nord America 3.991
EU - Europa 1.800
AS - Asia 475
Continente sconosciuto - Info sul continente non disponibili 6
SA - Sud America 5
OC - Oceania 4
AF - Africa 3
Totale 6.284
Nazione #
US - Stati Uniti d'America 3.921
IT - Italia 361
DE - Germania 358
CN - Cina 294
SE - Svezia 257
IE - Irlanda 207
UA - Ucraina 165
GB - Regno Unito 119
CA - Canada 70
DK - Danimarca 66
AT - Austria 63
RU - Federazione Russa 56
IN - India 51
HK - Hong Kong 48
FI - Finlandia 45
BE - Belgio 35
VN - Vietnam 32
FR - Francia 27
TR - Turchia 19
NL - Olanda 16
KR - Corea 12
ES - Italia 8
IR - Iran 6
SG - Singapore 5
CH - Svizzera 3
EU - Europa 3
JP - Giappone 3
TW - Taiwan 3
A2 - ???statistics.table.value.countryCode.A2??? 2
AU - Australia 2
BG - Bulgaria 2
BR - Brasile 2
CZ - Repubblica Ceca 2
MD - Moldavia 2
NO - Norvegia 2
NZ - Nuova Zelanda 2
PL - Polonia 2
SC - Seychelles 2
A1 - Anonimo 1
BO - Bolivia 1
CL - Cile 1
DZ - Algeria 1
EC - Ecuador 1
GR - Grecia 1
HU - Ungheria 1
ID - Indonesia 1
JO - Giordania 1
LI - Liechtenstein 1
ME - Montenegro 1
Totale 6.284
Città #
Ann Arbor 862
Woodbridge 462
Fairfield 339
Houston 292
Chandler 271
Wilmington 230
Frankfurt am Main 217
Ashburn 204
Dublin 200
Dearborn 166
Jacksonville 157
Cambridge 133
Seattle 132
New York 112
Milan 102
Princeton 81
Nanjing 64
Vienna 62
Hong Kong 48
Altamura 39
Lawrence 38
Shanghai 32
Brussels 30
Lachine 26
Tianjin 22
Nanchang 21
Shenyang 20
Dong Ket 18
Guangzhou 18
San Diego 18
Beijing 16
Fremont 16
Ottawa 15
Helsinki 14
Boston 13
Jinan 13
Andover 12
Boardman 12
Kunming 12
Edmonton 11
Lissone 11
Mountain View 10
Nürnberg 10
Philadelphia 10
Toronto 9
Changsha 8
Falls Church 8
Hebei 8
Jiaxing 8
Hangzhou 7
Ningbo 7
Zhengzhou 7
Busto Arsizio 6
Kiev 6
London 6
Manchester 6
Pune 6
Taizhou 6
Washington 6
Valencia 5
Valmadrera 5
Bergamo 4
Hounslow 4
Indianapolis 4
Montréal 4
Nottingham 4
Nutley 4
Padova 4
Sacramento 4
Seoul 4
Verona 4
Chicago 3
Hefei 3
Lanzhou 3
Los Angeles 3
Newtyle 3
Phoenix 3
Saint-Maurice-en-Gourgois 3
Segrate 3
Taipei 3
Tappahannock 3
Wenzhou 3
Aachen 2
Assèmini 2
Auburn Hills 2
Auckland 2
Beerse 2
Benevento 2
Bonndorf 2
Copenhagen 2
Daejeon 2
Delhi 2
Edinburgh 2
Foggia 2
Fuzhou 2
Genoa 2
Gent 2
Groningen 2
Gurgaon 2
Haikou 2
Totale 4.814
Nome #
Impact of multidisciplinary team approach to liver tumors: 5-Years experience 360
Impact of multidisciplinary team approach to liver tumors in a tertiary center: 5-years experience 334
Clinical outcome indicators in chronic hepatitis B and C: A primer for value-based medicine in hepatology 279
Diagnostic Value of Quantitative Perfusion Computed Tomography Technique in the Assessment of Tumor Response to Sorafenib in Patients with Advanced Hepatocellular Carcinoma 234
Optimising the clinical strategy for autoimmune liver diseases: Principles of value-based medicine 215
Diagnostic value of dynamic contrast-enhanced CT with perfusion imaging in the quantitative assessment of tumor response to sorafenib in patients with advanced hepatocellular carcinoma: A feasibility study 202
Mammalian target of rapamycin regulates vascular endothelial growth factor-dependent liver cyst growth in polycystin-2-defective mice 186
P1169 : Outcome indicators in primary sclerosing cholangitis: Interim analysis of the value-based medicine in hepatology study 185
P0811 : Sofosbuvir-based direct-acting antivirals treatment for elderly chronic hepatitis C patients: A cost-effectiveness analysis 182
Value-based outcome indicators in the management of hepatocellular carcinoma: Clinical test in a large multicenter study (VBMH study) 172
Dynamic contrast enhanced perfusion CT imaging: A diagnostic biomarker tool for survival prediction of tumour response to antiangiogenetic treatment in patients with advanced HCC lesions 172
Health Related Quality of Life in the Major Liver Conditions 169
Outcome indicators in primary sclerosing cholangitis: Interim analysis of the value-based medicine in hepatology study 169
Generation and performance of value-based outcome indicators in liver disease: The multicenter V.B.M.H. study 168
Outcome Indicators in Primary Sclerosing Cholangitis: Interim Analysis Of The Value-Based Medicine In Hepatology (VBMH) Study 166
Outcome indicators in liver cirrhosis: Application of value-based medicine in a large multicenter study (VBMH study) 165
Health related quality of life in chronic liver diseases 163
PGI36 Relationship Between Clinical Severity and Health Related Quality of Life in Chronic Liver Diseases 162
The impact of liver disease on the health-related quality of life 161
The Impact of Type of Liver Conditions on the Patients’ Health Related Quality of Life 159
Sofosbuvir-based all-oral treatment for elderly chronic hepatitis C patients: A cost-effectiveness analysis 159
Characteristics of patients with Chronic Hepatitis C who have failed past treatment or who have never been treated: How much room left for Interferon? 159
Value-based outcome indicators in liver cirrhosis: validation in a large multicenter study (VBMH study) 157
Generation and Performance of Outcome Indicators in Liver Cirrhosis: The Value Based Medicine in Hepatology Study (V.B.M.H.) 149
Measurement of clinical outcomes and quality of life indicators as a new value-based approach to liver cirrhosis management 148
PGI31 Health Care Indicators to Measure Quality of Care in Patients with Liver Diseases 147
Cyclic AMP/PKA-dependent paradoxical activation of Raf/MEK/ERK signaling in polycystin-2 defective mice treated with sorafenib 143
Liver-allocation policies for patients affected by HCC in Europe 140
Sorafenib paradoxically activates the raf/mek/erk signaling in mice with polycystic liver disease (pld) caused by conditional deletion of polycystin-2 137
Management of treatment-naïve chronic hepatitis C genotype 1 patients: A cost-effectiveness analysis of treatment options 136
Management of chronic hepatitis C (Chc) genotype 1 treatment-naïve patients in an era of rising opportunities and costs: A cost-effectiveness analysis 133
A Comparison Between The Health-Related Quality Of Life Reported By The General Population And By Patients With Major Liver Diseases 133
Direct-acting antivirals combination for elderly patients with chronic hepatitis C: A cost-effectiveness analysis 133
A value-based approach to the management of patients with liver cirrhosis through the systematic measurement of clinical outcome and quality of life indicators 132
Surgical management of hepatocellular carcinoma within and beyond BCLC indications in a middle volume center 129
Value-based approach to hepatocellular carcinoma: outcome indicators tested in a large multicenter study (VBMH study) 121
Impatto dei farmaci anti virali ad azione diretta sulla cura dei pazienti con epatite C: un approccio di value-based medicine 117
Is the risk of neoplastic recurrence increased after prescribing direct-acting antivirals for HCV patients whose HCC was previously cured? 96
Difference in health related quality of life of chronic liver diseases and general population 95
Applicazione della value-based medicine nella valutazione della cura dei pazienti affetti da epatite. 94
Totale 6.661
Categoria #
all - tutte 15.836
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 15.836


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/2019430 0 0 0 0 0 0 0 0 57 80 117 176
2019/20201.470 168 100 109 108 126 182 214 114 137 103 90 19
2020/2021929 46 55 109 111 93 73 59 85 77 83 59 79
2021/2022551 51 59 72 57 16 41 19 41 26 37 38 94
2022/20231.074 106 369 88 90 56 139 23 76 68 5 44 10
2023/2024595 23 29 19 57 64 213 127 24 39 0 0 0
Totale 6.661